Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity.


Proinflammatory eicosanoids (prostaglandins and leukotrienes) and specialized pro-resolving mediators (SPM) are temporally regulated during infections. Here we show that human macrophage phenotypes biosynthesize unique lipid mediator signatures when exposed to pathogenic bacteria. E. coli and S. aureus each stimulate predominantly proinflammatory 5-lipoxygenase (LOX) and cyclooxygenase pathways (i.e., leukotriene B4 and prostaglandin E2) in M1 macrophages. These pathogens stimulate M2 macrophages to produce SPMs including resolvin D2 (RvD2), RvD5, and maresin-1. E. coli activates M2 macrophages to translocate 5-LOX and 15-LOX-1 to different subcellular locales in a Ca(2+)-dependent manner. Neither attenuated nor non-pathogenic E. coli mobilize Ca(2+) or activate LOXs, rather these bacteria stimulate prostaglandin production. RvD5 is more potent than leukotriene B4 at enhancing macrophage phagocytosis. These results indicate that M1 and M2 macrophages respond to pathogenic bacteria differently, producing either leukotrienes or resolvins that further distinguish inflammatory or pro-resolving phenotypes.


PubMed ID: 29302056

Projects: A4

Journal: Nat Commun

Citation: Nat Commun. 2018 Jan 4;9(1):59. doi: 10.1038/s41467-017-02538-5.

Date Published: No date defined

Authors: Oliver Werz, J. Gerstmeier, S. Libreros, X. De la Rosa, Markus Werner, P. C. Norris, N. Chiang, C. N. Serhan

help Creator

Views: 313

Created: 10th Jan 2018 at 08:57

help Attributions


Related items

Powered by
Seek new full
Copyright © 2008 - 2019 The University of Manchester and HITS gGmbH